The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670502010) is a paclitaxel-coated percutaneous transluminal angioplasty balloon catheter engineered for the treatment of peripheral arterial disease. Featuring a 5 mm balloon diameter and 200 mm working length, the Ranger DCB is designed to deliver a controlled antiproliferative drug dose to the vessel wall while supporting predictable balloon performance during peripheral interventions.
Key Features
Paclitaxel drug coating with proprietary TransPax carrier technology designed for efficient drug transfer
Low nominal drug dose density of 2 µg/mm² intended to limit particulate loss
Balloon dimensions: 5 mm diameter x 200 mm length
Over-the-wire (OTW) catheter platform compatible with 0.035 inch guidewires
Low-profile balloon design intended to support crossability in long lesions
Radiopaque markers for fluoroscopic visualization of the working length
Clinical Applications
Percutaneous transluminal angioplasty of de novo or restenotic lesions in peripheral arteries
Treatment of long-segment lesions in the superficial femoral and proximal popliteal arteries
Adjunctive use in endovascular revascularization workflows for peripheral arterial disease
Refer to the manufacturer Instructions for Use for indications, contraindications, warnings and precautions
Product Information
Brand: Boston Scientific
Product Line: Ranger Drug-Coated PTA Balloon Catheter
REF/UPN: H74939670502010
Category: Peripheral Balloon Catheters
Balloon Diameter: 5 mm
Balloon Length: 200 mm
Drug Coating: Paclitaxel, 2 µg/mm²
Catheter Platform: Over-the-wire, 0.035 inch guidewire compatible
Usable Length: Not specified in the located sources
Sheath Compatibility: Not specified in the located sources
Sterility: Sterile, single-use device